Table 2: Clinical outcomes from Schulte-Kemna_2015 used for exploratory analysis.
|
Outcome |
Revascularization Group (n = 52) |
Conservative (Medical) Group (n = 33) |
Between-Group Difference / Notes |
|
Antihypertensive Drugs (mean #) |
↓ by 0.76 |
↑ by 0.47 |
Significant reduction vs increase (p < 0.0001) |
|
Blood Pressure (mmHg) |
↓ from 154/78 → 140/73 |
↓ from 159/74 → 150/80 |
Greater BP reduction with revascularization |
|
Hospitalization for Heart Failure (%) |
13.60% |
38.50% |
Significantly lower with revascularization (p = 0.016) |
|
Mortality (%) |
10% |
39.40% |
Significantly lower with revascularization (p = 0.041) |
|
Serum Creatinine (mg/dL) |
↓ from 2.2 → 1.8 |
~ 2.0 → 2.0 (no change) |
Trend toward improvement only in revascularization group |